Drug Shortage Report for ZYPREXA INTRAMUSCULAR

Last updated on 2022-07-08 History
Report ID 162425
Drug Identification Number 02247099
Brand name ZYPREXA INTRAMUSCULAR
Common or Proper name Olanzapine tartrate for injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 10MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 mL vial
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-06-24
Actual start date 2022-06-24
Estimated end date 2022-07-07
Actual end date 2022-07-07
Shortage status Resolved
Updated date 2022-07-08
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-07-08 English Compare
v9 2022-07-07 French Compare
v8 2022-07-07 English Compare
v7 2022-07-07 English Compare
v6 2022-06-27 French Compare
v5 2022-06-27 English Compare
v4 2022-06-25 English Compare
v3 2022-06-10 French Compare
v2 2022-06-10 French Compare
v1 2022-06-10 English Compare

Showing 1 to 10 of 10